click below
click below
Normal Size Small Size show me how
ERP Week 6
Intradermal (ID) Injection
Question | Answer |
---|---|
Intradermal injection sites include; | 1.The anterior portion of the inferior arm 2.The posterior portion of the superior arm 3.The superior portion of the back 4.The superior thorax |
Intradermal (ID) Tuburculin (TB) skin tests are usually performed on the clients; | Anterior forearm, 2-3 finger length from the antecubital space to a hands-width above the wrist |
The common length of an ID needle is; | 3/8 - 1/2 inch |
The common needle gauge (bore) for intradermal injection is | 25G to 30G |
An ID needle is inserted at a; | 10-15 degree angle with the bevel up (until the bevel disappears) |
A successful ID injection is achieved with the appearance of a; | Bleb / Wheal |
After the ID injection, quickly withdraw the needle, apply pressure to the injection site with a | Sterle 2x2, active the needle safety system, and dispose in a Sharps |
Document the ID injection in the clients chart including; | 1.Date 2.Military Time 3.Drug name 4.Dosage 5.Route 6.Site 7.Client reaction 8.Expiration Date 9.Lot number 10.Manufacture 11.Client education provided |
Intradermal (ID) injections are commonly used for; | 1.Allergy testing 2.TST - Tuberculin skin testing |
Tuberculin (TST) testing AKA | Tine Mantoux PPD |
A TST Tuberculin test should be evaluated; | 48 - 72hrs |
A positive TST test occurs when; | 1.15mm induration occurs (standard) 2.5mm induration for clients w/RA or CD 3.10mm induration for; Healthcare workers, diabetics or kidney disease 4.If vesiculation occurs (blisters) |